Skip to main content
. 2022 Oct 12;7(5):706–716. doi: 10.1089/can.2021.0058

Table 6.

Endorsed Side Effects of Cannabigerol-Predominant Cannabis and Percentage of Sessions for Which Side Effects Were Experienced (N=127)

Medical condition % endorsed N Range Mean, % Standard error
Dry mouth 16.5 21 9–100 52.71 5.66
Sleepiness 15 18 11–90 52.89 5.75
Increased appetite 11.8 14 9–90 51.14 6.42
Dry eyes 8.7 11 25–90 49.82 6.77
Nervousness/anxiety 6.3 8 5–58 26.25 6.04
Difficulty concentrating 6.3 6 30–100 59.18 10.44
Headrush/lightheaded/dizzy 6.3 7 2–74 28.57 11.49
Headache/migraine 5.5 7 2–60 21.57 7.91
More high 4.7 6 10–100 60.3 12.33
Heart palpitations/racing heart 3.1 3 30–51 40.33 6.06
Off-balance/unsteady 2.4 2 46–50 48 2
Paranoia 1.6 2 14–30 22 8
Hot flashes 0.8 1 91–91 91 0
Coughing fit 0        
Hallucinations 0        
Vomiting 0        
Other 9.4 11 10–100 46.55 10.57